|
|
|
 |
FDA Approval Activities for this Drug…
Zerit XR (stavudine) Extended-Release Capsules, 37.5 mg, 50 mg, 75 mg, and 100 mg, Bristol-Myers Squibb Company NDA 21-453 12/31/02 1/30/03 4/9/03 | ZERIT (stavudine) Capsules and Pediatric Solution (POS). Bristol-Myers Squibb Company NDA 20-412/S15 10/16/01 4/22/03 | ZERIT (stavudine) Capsules and Pediatric Solution (POS), Bristol-Myers Squibb Company NDA 20-412/S16 & 20-413/S7 3/29/02 4/8/02 3/29/02 | ZERIT (stavudine) Capsules and Pediatric Solution (POS). Bristol-Myers Squibb Company NDA 20-412/S17, S18 & 20-413/S8, S9 2/20/02 2/21/02 | ZERIT (stavudine) for Solution Bristol-Myers Squibb Company NDA 20-413/S6 Zerit (stavudine) Capsules, Bristol-Myers Squibb | | Zerit (stavudine) Powder for Oral Solution, Bristol-Myers Squibb | | Zerit XR Extended-Release, (stavudine) Capsules Bristol-Myers Squibb | ZERIT (stavudine) extended release capsules, Bristol-Myers Squibb, Labeling Revision | Stavudine Capsules, Aurobindo Pharma Limited, Tentative Approval | Stavudine Capsules, Aurobindo Pharma, Tentative Approval | Stavudine Capsules, Aurobindo Pharma, Tentative Approval | Stavudine Capsules, Strides Arcolab, Tentative Approval | Lamivudine, Stavudine, Nevirapine Tablets, Cipla Ltd., Tentative Approval | Stavudine/Lamivudine Tablets Co-packaged with Nevirapine Tablets, Strides Arcolab, Tentative Approval | Stavudine/Lamivudine Tablets, Strides Arcolab, Tentative Approval | Stavudine Capsules, Matrix Labs, Tentative Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Powder Oral Solution, Bristol-Myers Squibb, Labeling Revision | Stavudine/Lamivudine Tablets Co-packaged w/Efavirenz Tablets, Strides, Tentative Approval | Zerit (stavudine) Powder for Oral Solution, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Capsules, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Powder for Oral Solution, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Capsules, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Powder Oral Solution, Bristol-Myers Squibb, Labeling Revision | Lamivudine/Stavudine/Nevirapine Dispersible Tablets, Cipla Ltd., Tentative Approval | Stavudine Oral Solution, Cipla Ltd., Tentative Approval | Lamivudine/Stavudine Tablets, Matrix Labs, Tentative Approval | Stavudine Capsules, Emcure Pharma, Tentative Approval | Stavudine Capsules, InvaGen Pharma, Tentative Approval | Stavudine/Lamivudine/Nevirapine Tablets, Strides Arcolab, Tentative Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) For Oral Solution, Bristol-Myers Squibb, Control Supplement | Zerit (stavudine) For Oral Solution, Bristol-Myers Squibb, Labeling Revision | Stavudine Oral Solution, Aurobindo Pharma USA, Inc., Tentative Approval | Lamivudine/Stavudine Tablets, Cipla Ltd., Tentative Approval | Stavudine Capsules, Aurobindo Pharma USA, Inc., Tentative Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb Company, Labeling Revision | Zerit (stavudine) Oral Solution, Bristol-Myers Squibb Company, Labeling Revision | Stavudine Capsules, Hetero Drugs Ltd., Approval | Stavudine Capsules, Matrix Laboratories, Inc., Approval | Stavudine Capsules, Aurobindo Pharma Ltd., Approval | Stavudine Oral Solution, Aurobindo Pharma Ltd., Approval | Stavudine Capsules, Matrix Laboratories, Ltd., Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb Co., Labeling Revision | Zerit (stavudine) Oral Solution, Bristol-Myers Squibb Co., Labeling Revision | Stavudine, Lamivudine and Nevirapine Tablets, Pharmacare Ltd., Tentative Approval | Stavudine Oral Solution, Cipla Ltd., Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb Co., Labeling Revision | Zerit (stavudine) Oral Solution, Bristol-Myers Squibb Co., Labeling Revision | Stavudine, Lamivudine, and Nevirapine Tablets, Emcure Pharmaceuticals, Ltd., Tentative Approval | Lamivudine and Stavudine Tablets, Hetero Drugs Ltd., Tentative Approval | Lamivudine, Nevirapine, and Stavudine Tablets, Macleods Pharmaceuticals Ltd., Tentative Approval | Zerit (stavudine) Capsules, Bristol-Myers Squibb Co., Labeling Revision | Zerit (stavudine) Oral Solution, Bristol-Myers Squibb Co., Labeling Revision | Zerit (stavudine) Capsules, Bristol-Myers Squibb, Labeling Revision | Zerit (stavudine) Oral Solution, Bristol-Myers Squibb, Labeling Revision
  
|